{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:19:04Z","timestamp":1776986344804,"version":"3.51.4"},"reference-count":25,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T00:00:00Z","timestamp":1450051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Primary myelofibrosis (PMF), per WHO criteria, is a clonal myeloproliferative neoplasm that usually presents with a proliferation of granulocytic and megakaryocytic lineages with an associated fibrous deposition and extramedullary hematopoiesis. The bone marrow histologic findings of this disorder are typically characterized by the presence of myeloid metaplasia with an associated reactive fibrosis, angiogenesis, and osteosclerosis. However, marked myelofibrosis is not solely confined to PMF and may also be associated with other conditions including but not limited to acute megakaryoblastic leukemias (FAB AML-M7). Here, we describe a rare case of a non-megakaryoblastic acute myeloid leukemia with marked myelofibrosis with osteosclerosis and an isolated trisomy 19. A 19-year-old male presented with severe bone pain of one week duration with a complete blood cell count and peripheral smear showing a mild anemia and occasional circulating blasts. A follow up computed tomography (CT) scan showed diffuse osteosclerosis with no evidence of hepatosplenomegaly or lymphadenopathy. Subsequently, the bone marrow biopsy showed markedly sclerotic bony trabeculae and a hypercellular marrow with marked fibrosis and intervening sheets of immature myeloid cells consistent with myeloblasts with monocytic differentiation. Importantly, these myeloblasts were negative for megakaryocytic markers (CD61 and vWF), erythroid markers (hemoglobin and E-cadherin), and lymphoid markers (CD3, CD19, and TdT). Metaphase cytogenetics showed an isolated triosomy 19 with no JAK2 V617F mutation. The patient was treated with induction chemotherapy followed by allogenic hematopoietic stem cell transplantation which subsequently resulted in a rapid resolution of bone marrow fibrosis, suggesting graft-anti-fibrosis effect. This is a rare case of a non-megakaryoblastic acute myeloid leukemia with myelofibrosis and osteosclerosis with trisomy 19 that may provide insights into the prognosis and therapeutic options of future cases.<\/jats:p>","DOI":"10.3390\/cancers7040903","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T10:21:33Z","timestamp":1450088493000},"page":"2459-2465","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis"],"prefix":"10.3390","volume":"7","author":[{"given":"Adam","family":"Stelling","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, PATH Bldg. 4400 V Street, Sacramento, CA 95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-5809","authenticated-orcid":false,"given":"Brian","family":"Jonas","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of California Davis Medical Center, Sacramento, CA 95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooman","family":"Rashidi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, PATH Bldg. 4400 V Street, Sacramento, CA 95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Abedi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of California Davis Medical Center, Sacramento, CA 95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, PATH Bldg. 4400 V Street, Sacramento, CA 95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.2007.06807.x","article-title":"Bone marrow fibrosis: Pathophysiology and clinical significance of increased bone marrow stromal fibres","volume":"139","author":"Kuter","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"ref_3","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.1981.tb07191.x","article-title":"Acute myelodysplasia with myelofibrosis: A report of eight cases","volume":"49","author":"Sultan","year":"1981","journal-title":"Br. J. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI19540","article-title":"TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia","volume":"113","author":"Shehata","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/ijlh.12101","article-title":"Differential diagnosis of myelofibrosis based on WHO 2008 criteria: Acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis","volume":"35","author":"Bae","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ajh.20141","article-title":"Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis","volume":"77","author":"Sato","year":"2004","journal-title":"Am. J. Hematol."},{"key":"ref_8","first-page":"174","article-title":"Two cases of trisomy 19 as a sole chromosomal abnormality in myeloid disorders","volume":"28","author":"Jung","year":"2008","journal-title":"Korean J. Lab. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/gcc.1192","article-title":"Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization","volume":"32","author":"Alvarez","year":"2001","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2002-07-2225","article-title":"Chromosome 19 abnormalities are commonly seen in AML, M7","volume":"100","author":"Nimer","year":"2002","journal-title":"Blood"},{"key":"ref_11","first-page":"999","article-title":"Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management","volume":"89","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00043426-198824000-00010","article-title":"Acute monoblastic leukemia with osteosclerosis and extensive myelofibrosis","volume":"10","author":"Janin","year":"1988","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1200\/JCO.2011.37.4983","article-title":"Diffuse osteosclerosis-associated acute myeloid leukemia","volume":"30","author":"Ward","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/modpathol.2013.187","article-title":"Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems","volume":"27","author":"Fu","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_15","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W. (2008). WHO Classification of Tumours of Hematopoietic and Lymphoid Tissue, IARC Press."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.23703","article-title":"Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Tefferi","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1186\/1755-1536-5-S1-S20","article-title":"Primary myelofibrosis and the \u201cbad seeds in bad soil\u201d concept","volume":"5","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/ehm.09.17","article-title":"Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis","volume":"2","author":"Varricchio","year":"2009","journal-title":"Expert Rev. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mayocp.2011.11.001","article-title":"One thousand patients with primary myelofibrosis: The mayo clinic experience","volume":"87","author":"Tefferi","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/modpathol.3800348","article-title":"Acute panmyelosis with myelofibrosis: An entity distinct from acute megakaryoblastic leukemia","volume":"18","author":"Orazi","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2013042","DOI":"10.4084\/mjhid.2013.042","article-title":"Acute panmyelosis with myelofibrosis\u2014A rare subtype of acute myeloid leukemia","volume":"5","author":"Chatterjee","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood.V124.21.959.959","article-title":"Comparison of acute panmyelosis with myelofibrosis and acute megakaryoblastic leukemia: A Mayo clinic study","volume":"124","author":"Gangat","year":"2014","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1200\/JCO.2004.00.9316","article-title":"Pathogenesis of myelofibrosis with myeloid metaplasia","volume":"23","author":"Tefferi","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1309\/09NP-3DFG-BLM9-E5LE","article-title":"Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders","volume":"117","author":"Douglas","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.5858\/arpa.2012-0151-CR","article-title":"An unusual case of Philadelphia chromosome-positive chronic myelogenous leukemia with trisomy 19 presenting with megakaryoblastosis and myelofibrosis","volume":"137","author":"Aljinovic","year":"2013","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/7\/4\/903\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:54:02Z","timestamp":1760216042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/7\/4\/903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,14]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["cancers7040903"],"URL":"https:\/\/doi.org\/10.3390\/cancers7040903","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,14]]}}}